MRI and the Evaluation of the Blood-Spinal Cord Barrier following Injury

References

1. ↵
   Mautes AE, Weinzierl MR, Donovan F, Noble LJ. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000;80:673–687

   Abstract/FREE Full Text
2. ↵
   Pan W, Kastin AJ, Gera L, Stewart JM. Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice. Neurosci Lett 2001;307:25–28

   CrossRefPubMed
3. ↵
   Kakulas BA. A review of the neuropathology of human spinal cord injury with emphasis on special features. J Spinal Cord Med 1999;22:119–124

   PubMed
4. ↵
   Noble LJ, Donovan F, Igarashi T, et al. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002;22:7526–7535

   Abstract/FREE Full Text
5. ↵
   Wells JE, Rice TK, Nuttall RK, et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 2003;23:10107–10115

   Abstract/FREE Full Text
6. ↵
   Bilgen M, Abbe R, Narayana PA. Dynamic contrast-enhanced MRI of experimental spinal cord injury: in vivo serial studies. Magn Reson Med 2001;45:614–622

   PubMed
7. ↵
   Runge VM, Wells JW, Baldwin SA, et al. Evaluation of the temporal evolution of acute spinal cord injury. Invest Radiol 1997;32:105–110

   CrossRefPubMedWeb of Science